Biomarkers may help ID patients at increased risk of neurotoxicity from CD19 CAR T-cell therapy
Bottom Line: New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR...






